{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:03Z","timestamp":1740126423542,"version":"3.37.3"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"9-10","license":[{"start":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T00:00:00Z","timestamp":1505260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10354-017-0598-7","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T09:23:16Z","timestamp":1505294596000},"page":"203-214","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impfen ist nicht nur Kindersache!","Immunizing is not only a children\u2019s matter!"],"prefix":"10.1007","volume":"169","author":[{"given":"Ursula","family":"Kunze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest","family":"Groman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,13]]},"reference":[{"key":"598_CR1","first-page":"814","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","unstructured":"Centers for Disease Control and Prevention (CDC). Ten great public health achievements \u2013 worldwide, 2001\u20132010. MMWR Morb Mortal Wkly Rep. 2011;60:814\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"598_CR2","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1001\/jama.298.18.2155","volume":"298","author":"SW Roush","year":"2007","unstructured":"Roush SW, Murphy TV. Vaccine-preventable disease table working group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the united states. JAMA. 2007;298:2155\u201363.","journal-title":"JAMA"},{"key":"598_CR3","volume-title":"State of the world\u2019s vaccines and immunization","author":"World Health Organization","year":"2009","unstructured":"World Health Organization, UNICEF, World Bank. State of the world\u2019s vaccines and immunization. 3.\u00a0Aufl. Geneva: World Health Organization; 2009.","edition":"3"},{"key":"598_CR4","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2014.933077","author":"S Wicker","year":"2014","unstructured":"Wicker S, Maltezou HC. Vaccine-preventable diseases in Europe: where do we stand? Expert Rev Vaccines. 2014; https:\/\/doi.org\/10.1586\/14760584.2014.933077 .","journal-title":"Expert Rev Vaccines"},{"key":"598_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2807\/ese.15.50.19748-en","volume":"15","author":"W Otto","year":"2010","unstructured":"Otto W, Mankertz A, Santibanez S, et\u00a0al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill. 2010;15:21\u20134.","journal-title":"Euro Surveill"},{"key":"598_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.annder.2010.12.015","volume":"138","author":"G Monsel","year":"2011","unstructured":"Monsel G, Rapp C, Duong TA, et\u00a0al. Measles in adults: an emerging disease not sparing medical staff. Ann Dermatol Venereol. 2011;138:107\u201310.","journal-title":"Ann Dermatol Venereol"},{"key":"598_CR7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/ese.15.35.19654-en","volume":"15","author":"AS Barret","year":"2010","unstructured":"Barret AS, Ryan A, Breslin A, et\u00a0al. Pertussis outbreak in northwest Ireland, January\u2013June 2010. Euro Surveill. 2010;15:3\u20137.","journal-title":"Euro Surveill"},{"key":"598_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/1469-0691.12537","volume":"20","author":"C Bonanni","year":"2014","unstructured":"Bonanni C, Donato SR, et al. Lifelong vaccination as a\u00a0key disease-prevention strategy. Clin Microbiol Infect. 2014;20:32\u20136.","journal-title":"Clin Microbiol Infect"},{"key":"598_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S1473-3099(11)70007-X","volume":"11","author":"F Zepp","year":"2011","unstructured":"Zepp F, Heininger U, Mertsola J, et\u00a0al. Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis. 2011;11:557\u201370.","journal-title":"Lancet Infect Dis"},{"key":"598_CR10","volume-title":"Annual Epidemiological Report 2016 \u2013 Pertussis. [Internet]. Stockholm: ECDC","author":"European Centre for Disease Prevention and Control","year":"2016","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report 2016 \u2013 Pertussis. [Internet]. Stockholm: ECDC. 2016. http:\/\/ecdc.europa.eu\/en\/healthtopics\/Pertussis\/Pages\/Annual-epidemiological-report-2016.aspx . Zugegriffen: 15.2.2017."},{"key":"598_CR11","volume-title":"Lebenserwartung","author":"Statistik Austria","year":"2017","unstructured":"Statistik Austria. Lebenserwartung. 2017. http:\/\/www.statistikaustria.at\/web_de\/statistiken\/menschen_und_gesellschaft\/bevoelkerung\/sterbetafeln\/index.html . Zugegriffen: 20.2.2017."},{"key":"598_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/S0140-6736(16)32381-9","volume":"389","author":"V Kontis","year":"2017","unstructured":"Kontis V, Bennett JE, Mathers CD, et\u00a0al. Future life expectancy in 35 industrialized countries: projections with a\u00a0Bayesian model ensemble. Lancet. 2017;389:1323\u201335. https:\/\/doi.org\/10.1016\/S0140-6736(16)32381-9 .","journal-title":"Lancet"},{"key":"598_CR13","volume-title":"World population ageing 2015 (ST\/ESA\/SER.A\/390)","author":"United Nations Department of Economic and Social Affairs. Population Division","year":"2015","unstructured":"United Nations Department of Economic and Social Affairs. Population Division. World population ageing 2015 (ST\/ESA\/SER.A\/390). 2015. http:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/ageing\/WPA2015_Report.pdf . Zugegriffen: 20.2.2017."},{"key":"598_CR14","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1016\/j.vaccine.2009.01.069","volume":"27","author":"GA Poland","year":"2009","unstructured":"Poland GA, Jacobson RM, Ovsyannikova IG. Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics. Vaccine. 2009;27:3240\u20134. https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.069 .","journal-title":"Vaccine"},{"key":"598_CR15","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1016\/S0140-6736(12)62087-X","volume":"381","author":"B Rechel","year":"2013","unstructured":"Rechel B, Grundy E, Robine LM, et\u00a0al. Ageing in the European Union. Lancet. 2013;381:1312\u201322.","journal-title":"Lancet"},{"key":"598_CR16","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","volume":"10","author":"A Marengonia","year":"2011","unstructured":"Marengonia A, Anglemana S, Melisa R, et\u00a0al. Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev. 2011;10:430\u20139. https:\/\/doi.org\/10.1016\/j.arr.2011.03.003 .","journal-title":"Ageing Res. Rev."},{"key":"598_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ccc.2013.03.016","volume":"29","author":"HJ Heppner","year":"2013","unstructured":"Heppner HJ, Sieber C, Walger P, et\u00a0al. Infections in the elderly. Crit Care Clin. 2013;29:757\u201374.","journal-title":"Crit Care Clin"},{"key":"598_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","volume":"4","author":"J Pearson-Stuttard","year":"2016","unstructured":"Pearson-Stuttard J, Blundell S, Harris T, et al. Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol. 2016;4:148\u201358.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"598_CR19","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.1016\/j.vaccine.2016.11.015","volume":"52","author":"M Doherty","year":"2016","unstructured":"Doherty M, Schmidt-Ott R, Santos JI, et al. Vaccination of special populations: protecting the vulnerable. Vaccine. 2016;52:6681\u201390. https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.015 .","journal-title":"Vaccine"},{"key":"598_CR20","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1007\/s00063-010-1137-0","volume":"105","author":"HJ Hutt","year":"2010","unstructured":"Hutt HJ, Bennerscheidt P, Thiel B, et\u00a0al. Immunseneszenz und Impfungen im h\u00f6heren Lebensalter. Med Klin. 2010;105:802\u20137.","journal-title":"Med Klin"},{"key":"598_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399407000221","volume":"9","author":"RD Kovaiou","year":"2007","unstructured":"Kovaiou RD, Herndler-Brandstetter D, Grubeck-Loebenstein B. Age-related changes in immunity: implications for vaccination in the elderly. Expert Rev Mol Med. 2007;9:1\u201317.","journal-title":"Expert Rev Mol Med"},{"key":"598_CR22","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","volume":"26","author":"PH Lambert","year":"2008","unstructured":"Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine. 2008;26:3197\u2013208.","journal-title":"Vaccine"},{"key":"598_CR23","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","volume":"23","author":"E Grimprel","year":"2005","unstructured":"Grimprel E, von Sonnenburg F, Sanger R, et al. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Vaccine. 2005;23:3657\u201367.","journal-title":"Vaccine"},{"key":"598_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.vaccine.2003.08.012","volume":"22","author":"P Damme van","year":"2004","unstructured":"van Damme P, Burgess M. Immunogenicity of a\u00a0combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine. 2004;22:305\u20138.","journal-title":"Vaccine"},{"key":"598_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/01.mej.0000184993.51799.ad","volume":"13","author":"T Hoel","year":"2006","unstructured":"Hoel T, Wolter JM, Schuerman LM. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults. Eur J Emerg Med. 2006;13:67\u201371.","journal-title":"Eur J Emerg Med"},{"key":"598_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1136\/bmj.320.7229.217","volume":"320","author":"A Vellinga","year":"2000","unstructured":"Vellinga A, Van DP, Joossens E, et\u00a0al. Response to diphtheria booster vaccination in healthy adults: vaccine trial. BMJ. 2000;320:217.","journal-title":"BMJ"},{"key":"598_CR27","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1016\/j.vaccine.2011.06.049","volume":"29","author":"P Damme Van","year":"2011","unstructured":"Van Damme P, McIntyre P, Grimprel E, et al. Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(R)) in adults 55 years of age and over: a\u00a0sub-analysis of four trials. Vaccine. 2011;29:5932\u20139.","journal-title":"Vaccine"},{"key":"598_CR28","doi-asserted-by":"publisher","first-page":"e82967","DOI":"10.1371\/journal.pone.0082967","volume":"8","author":"B Weinberger","year":"2013","unstructured":"Weinberger B, Schirmer M, Matteucci GR, et\u00a0al. Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. PLOS ONE. 2013;8:e82967.","journal-title":"PLOS ONE"},{"key":"598_CR29","doi-asserted-by":"publisher","first-page":"2014385","DOI":"10.1098\/rspb.2014.3085","volume":"282","author":"AK Simon","year":"2015","unstructured":"Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282:2014385. https:\/\/doi.org\/10.1098\/rspb.2014.3085 .","journal-title":"Proc Biol Sci."},{"key":"598_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/rej.2010.1078","volume":"14","author":"JP Michel","year":"2011","unstructured":"Michel JP, Lang O. Promoting life course vaccination. Rejuvenation Res. 2011;14:75\u201381. https:\/\/doi.org\/10.1089\/rej.2010.1078 .","journal-title":"Rejuvenation Res"},{"key":"598_CR31","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.amjmed.2010.07.032","volume":"124","author":"H Pham","year":"2011","unstructured":"Pham H, Geraci SA, Burton MJ. CDC Advisory Committee on Immunization Practices Adult immunizations: update on recommendations. Am J Med. 2011;124:698\u2013701. https:\/\/doi.org\/10.1016\/j.amjmed.2010.07.032 .","journal-title":"Am J Med"},{"key":"598_CR32","volume-title":"Geb\u00e4rmutterhalskrebs","author":"Statistik Austria","year":"2017","unstructured":"Statistik Austria. Geb\u00e4rmutterhalskrebs. 2017. http:\/\/www.statistik.at\/web_de\/statistiken\/menschen_und_gesellschaft\/gesundheit\/krebserkrankungen\/gebaermutterhals\/index.html . Zugegriffen: 23.3.2017."},{"key":"598_CR33","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.vaccine.2015.12.052","volume":"34","author":"M Kristensen","year":"2016","unstructured":"Kristensen M, van Lier A, Eilers R, et\u00a0al. Burden of four vaccine preventable diseases in older adults. Vaccine. 2016;34:942\u20139.","journal-title":"Vaccine"},{"key":"598_CR34","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1086\/313792","volume":"30","author":"TT Yoshikawa","year":"2000","unstructured":"Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis. 2000;30:931\u20133.","journal-title":"Clin Infect Dis"},{"key":"598_CR35","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S1473-3099(02)00437-1","volume":"11","author":"G Gavazzi","year":"2002","unstructured":"Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis. 2002;11:659\u201366.","journal-title":"Lancet Infect Dis"},{"key":"598_CR36","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1016\/j.vaccine.2009.01.127","volume":"27","author":"AG Jansen","year":"2009","unstructured":"Jansen AG, Rodenburg GD, de Greeff SC, et\u00a0al. Invasive pneumococcal disease in the Netherlands: syndromes, outcome and potential vaccine benefits. Vaccine. 2009;27:2394\u2013401.","journal-title":"Vaccine"},{"key":"598_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1086\/426082","volume":"40","author":"KP High","year":"2005","unstructured":"High KP, Bradley S, Loeb M, et\u00a0al. A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a\u00a0risk factor and outcome measure. Clin Infect Dis. 2005;40:114\u201322.","journal-title":"Clin Infect Dis"},{"key":"598_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/2051013615599151","volume":"4","author":"RW Johnson","year":"2015","unstructured":"Johnson RW, Alvarez-Pasquin M, Bijl M, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a\u00a0multidisciplinary perspective. Ther Adv Vaccines. 2015;4:109\u201320. https:\/\/doi.org\/10.1177\/2051013615599151 .","journal-title":"Ther Adv Vaccines"},{"key":"598_CR39","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.4161\/hv.23491","volume":"9","author":"M Drolet","year":"2013","unstructured":"Drolet M, Oxman MN, Levin MJ, et\u00a0al. Vaccination against herpes zoster in developed countries. State of the evidence. Hum Vaccin Immunother. 2013;9:1177\u201384.","journal-title":"Hum Vaccin Immunother"},{"key":"598_CR40","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa051016","volume":"352","author":"MN Oxman","year":"2005","unstructured":"Oxman MN, Levin MJ, Johnson GR, et\u00a0al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N\u00a0Engl J Med. 2005;352:2271\u201384.","journal-title":"N Engl J Med"},{"key":"598_CR41","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/cid\/cir970","volume":"54","author":"KE Schmader","year":"2012","unstructured":"Schmader KE, Levin MJ, Gnann JW, et\u00a0al. Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50\u201359 years. Clin Infect Dis. 2012;54:922\u20138.","journal-title":"Clin Infect Dis"},{"key":"598_CR42","volume-title":"Fact sheet Influenza No.\u00a0211","author":"World Health Organization (WHO)","year":"2009","unstructured":"World Health Organization (WHO). Fact sheet Influenza No.\u00a0211. 2009. http:\/\/www.who.int\/mediacentre\/factsheets\/2003\/fs211\/en ."},{"key":"598_CR43","volume-title":"Fact sheet for health professionals on seasonal influenza","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2017","unstructured":"European Centre for Disease Prevention and Control (ECDC). Fact sheet for health professionals on seasonal influenza. 2017. https:\/\/ecdc.europa.eu\/en\/seasonal-influenza\/facts\/key-messages . Zugegriffen: 23.3.2017."},{"key":"598_CR44","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00508-011-0019-7","volume":"123","author":"HW Kuo","year":"2011","unstructured":"Kuo HW, Schmid D, Liu YL, et al. Influenza-related excess mortality, Austria 2001 till 2009. Wien Klin Wochenschr. 2011;123:593\u20138. https:\/\/doi.org\/10.1007\/s00508-011-0019-7 .","journal-title":"Wien Klin Wochenschr"},{"key":"598_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-012-9701-y","volume":"27","author":"M Redlberger-Fritz","year":"2012","unstructured":"Redlberger-Fritz M, Aberle JH, Popow-Kraupp T, et al. Attributable deaths due to influenza: a\u00a0comparative study of seasonal and pandemic influenza. Eur J Epidemiol. 2012;27:567\u201375. https:\/\/doi.org\/10.1007\/s10654-012-9701-y .","journal-title":"Eur J Epidemiol"},{"key":"598_CR46","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.1016\/j.vaccine.2013.08.050","volume":"44","author":"U Kunze","year":"2013","unstructured":"Kunze U, B\u00f6hm G, Groman E. Influenza vaccination in Austria, 1982\u20132011. Vaccine. 2013;44:5099\u2013103. https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.050 .","journal-title":"Vaccine"},{"key":"598_CR47","volume-title":"Impfplan \u00d6sterreich 2017","author":"Bundesministerium f\u00fcr Gesundheit und Frauen","year":"2017","unstructured":"Bundesministerium f\u00fcr Gesundheit und Frauen. Impfplan \u00d6sterreich 2017. 2017. http:\/\/www.bmgf.gv.at\/home\/Impfplan . Zugegriffen: 14.2.2017."},{"key":"598_CR48","first-page":"23","volume":"47","author":"World Health Organization (WHO)","year":"2012","unstructured":"World Health Organization (WHO). Vaccines against Influenza-WHO position paper. Wkly Epidemiol Rec. 2012;47:23.","journal-title":"Wkly Epidemiol Rec"},{"key":"598_CR49","volume-title":"Factsheet measles","author":"World Health Organization (WHO)","year":"2015","unstructured":"World Health Organization (WHO). Factsheet measles. 2015. http:\/\/www.euro.who.int\/en\/media-centre\/sections\/fact-sheets\/2015\/measles-in-the-who-european-region . Zugegriffen: 29.3.2017."},{"key":"598_CR50","volume-title":"Monthly measles epidemiological updates","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2017","unstructured":"European Centre for Disease Prevention and Control (ECDC). Monthly measles epidemiological updates. 2017. http:\/\/ecdc.europa.eu\/en\/healthtopics\/measles\/epidemiological_data\/Pages\/measles_surveillance_reports.aspx ."},{"key":"598_CR51","volume-title":"Masern-aktuelle Situation in \u00d6sterreich","author":"Bundesministerium f\u00fcr Gesundheit und Frauen","year":"2017","unstructured":"Bundesministerium f\u00fcr Gesundheit und Frauen. Masern-aktuelle Situation in \u00d6sterreich. 2017. https:\/\/www.bmgf.gv.at\/home\/Masern . Zugegriffen: 8.6.2017."},{"issue":"Supplement 1","key":"598_CR52","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.1093\/infdis\/jir067","volume":"204","author":"M. Muscat","year":"2011","unstructured":"Muscat M. Who gets measles in Europe? J\u00a0Infect Dis. 2011;(Suppl 1):S353\u2013S65. https:\/\/doi.org\/10.1093\/infdis\/jir067 .","journal-title":"Journal of Infectious Diseases"},{"key":"598_CR53","volume-title":"Immunization, vaccines and biologicals \u2013 pertussis","author":"World Health Organization (WHO)","year":"2008","unstructured":"World Health Organization (WHO). Immunization, vaccines and biologicals \u2013 pertussis. 2008. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/passive\/pertussis\/en\/ . Zugegriffen: 23.3.2017."},{"key":"598_CR54","volume-title":"Pertussis","author":"Zentrum f\u00fcr Reisemedizin","year":"2017","unstructured":"Zentrum f\u00fcr Reisemedizin. Pertussis. 2017. http:\/\/www.reisemed.at\/krankheiten\/keuchhusten-pertussis . Zugegriffen: 23.3.2017."},{"key":"598_CR55","doi-asserted-by":"publisher","first-page":"D60","DOI":"10.1016\/j.vaccine.2015.05.102","volume":"33","author":"T Pilishvili","year":"2015","unstructured":"Pilishvili T, Bennett NM. Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines. Vaccine. 2015;33:D60\u2013D5.","journal-title":"Vaccine"},{"key":"598_CR56","volume-title":"Annual Epidemiological Report 2016 \u2013 Invasive pneumococcal disease","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2016","unstructured":"European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2016 \u2013 Invasive pneumococcal disease. 2016. http:\/\/ecdc.europa.eu\/en\/healthtopics\/pneumococcal_infection\/Pages\/Annual-epidemiological-report-2016.aspx . Zugegriffen: 29.3.2017."},{"key":"598_CR57","volume-title":"Jahresbericht Nationale Referenzzentrale f\u00fcr Pneumokokken","author":"\u00d6sterreichische Agentur f\u00fcr Gesundheit und Ern\u00e4hrungssicherheit (AGES)","year":"2014","unstructured":"\u00d6sterreichische Agentur f\u00fcr Gesundheit und Ern\u00e4hrungssicherheit (AGES), Institut f\u00fcr medizinische Mikrobiologie und Hygiene Graz. Jahresbericht Nationale Referenzzentrale f\u00fcr Pneumokokken. 2014. https:\/\/www.bmgf.gv.at\/cms\/home\/attachments\/8\/7\/9\/CH1470\/CMS1426082563865\/jb_pneumokokken_2014_-_format_elbel_10032015.pdf . Zugegriffen: 27.6.2017."},{"key":"598_CR58","first-page":"373","volume":"42","author":"World Health Organization (WHO)","year":"2008","unstructured":"World Health Organization (WHO). WHO position paper \u2013 23-valent pneumococcal polysaccharide vaccine. Wkly Epidemiol Rec. 2008;42:373\u201384.","journal-title":"Wkly Epidemiol Rec"},{"key":"598_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3238\/arztebl.2016.0139","volume":"4113","author":"H Ewald","year":"2016","unstructured":"Ewald H, Briel M, Vuichard D, et al. The clinical effectiveness of pneumococcal conjugate vaccines: a systematic review and meta-analysis of randomized controlled trials. Dtsch Arztebl Int. 2016;4113:139\u201346. https:\/\/doi.org\/10.3238\/arztebl.2016.0139 .","journal-title":"Dtsch Arztebl Int"},{"key":"598_CR60","volume-title":"Annual Epidemiological Report 2016 \u2013 Poliomyelitis","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2016","unstructured":"European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report 2016 \u2013 Poliomyelitis. 2016. https:\/\/ecdc.europa.eu\/en\/publications-data\/polio-annual-epidemiological-report-2016-2014-data . Zugegriffen: 9.3.2017."},{"key":"598_CR61","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(13)62223-0","volume":"383","author":"LP Celentano","year":"2014","unstructured":"Celentano LP, Lopalco PL, Huitric E, et\u00a0al. Polio and the risk for the European Union. Lancet. 2014;383:216\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(13)62223-0 .","journal-title":"Lancet"},{"key":"598_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/cei.12822","volume":"187","author":"B Weinberger","year":"2017","unstructured":"Weinberger B. Adult vaccination against tetanus and diphtheria: the European perspective. Clin Exp Immunol. 2017;187:93\u20139. https:\/\/doi.org\/10.1111\/cei.12822 .","journal-title":"Clin Exp Immunol"},{"key":"598_CR63","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1017\/S0950268812000210","volume":"141","author":"P Giovine Di","year":"2013","unstructured":"Di Giovine P, Kafatos G, Nardone A, et\u00a0al. Comparative seroepidemiology of diphtheria in six European countries and Israel. Epidemiol Infect. 2013;141:132\u201342.","journal-title":"Epidemiol Infect"},{"key":"598_CR64","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.vaccine.2011.12.091","volume":"30","author":"R Chlibek","year":"2012","unstructured":"Chlibek R, Anca I, Andr\u00e9 F, et\u00a0al. Adult vaccination in 11 Central European countries \u2013 Calendars are not just for children. Vaccine. 2012;30:1529\u201340.","journal-title":"Vaccine"},{"key":"598_CR65","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1016\/j.vaccine.2012.06.012","volume":"30","author":"EE Kanitz","year":"2012","unstructured":"VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points, Kanitz EE, Wu LA, Giambia C, et\u00a0al. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine. 2012;30:5222\u20138.","journal-title":"Vaccine"},{"key":"598_CR66","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejim.2016.04.021","volume":"33","author":"L Ozisik","year":"2016","unstructured":"European Federation of Internal Medicine ADVICE Working Group, Ozisik L, Tanriover TM, Rigby S. ADVICE for a\u00a0healthier life: adult vaccination campaign in Europe. Eur J Intern Med. 2016;33:14\u201320.","journal-title":"Eur. J. Intern. Med."},{"key":"598_CR67","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00038-012-0438-x","volume":"58","author":"LA Wu","year":"2013","unstructured":"Wu LA, Kanitz E, Crumly J, et\u00a0al. Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage. Int J Public Health. 2013;58:865\u201374. https:\/\/doi.org\/10.1007\/s00038-012-0438-x .","journal-title":"Int J Public Health"},{"key":"598_CR68","unstructured":"Vaccine European New Integrated Collaboration Effort (Venice I\u2013III). 2017. http:\/\/venice.cineca.org\/the_project.html . Zugegriffen: 9.3.2017."},{"key":"598_CR69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/1469-0691.12453","volume":"20","author":"PL Lopalco","year":"2014","unstructured":"Lopalco PL, Carrillo Sanstisteve P. Actual immunization coverage throughout Europe: are existing data sufficient? Clin Microbiol Infect. 2014;20:7\u201311.","journal-title":"Clin Microbiol Infect"},{"key":"598_CR70","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1016\/j.vaccine.2015.08.082","volume":"33","author":"A Palache","year":"2015","unstructured":"Palache A, Oriol-Mathieu V, Fino M, et al. Seasonal influenza vaccine dose distribution in 195 countries (2004\u20132013): little progress in estimated global vaccination coverage. Vaccine. 2015;33:5598\u2013605.","journal-title":"Vaccine"},{"key":"598_CR71","volume-title":"Seasonal influenza vaccination and antiviral use in Europe \u2013 Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013\u201314 and 2014\u201315 influenza season","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2016","unstructured":"European Centre for Disease Prevention and Control (ECDC). Seasonal influenza vaccination and antiviral use in Europe \u2013 Overview of vaccination recommendations and coverage rates in the EU Member States for the 2013\u201314 and 2014\u201315 influenza season. 2016. http:\/\/ecdc.europa.eu\/en\/publications\/_layouts\/forms\/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&ID=1528 . Zugegriffen: 9.3.2017."},{"key":"598_CR72","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/eurpub\/ckw006","volume":"26","author":"K Hoffman","year":"2016","unstructured":"Hoffman K, Paget J, Wojczewski S, et al. Influenza vaccination prevalence and demographic factors of patients and GPs in primary care in Austria and Croatia: a\u00a0cross-sectional comparative study in the framework of the APRES project. Eur J Public Health. 2016;26:395\u2013401. https:\/\/doi.org\/10.1093\/eurpub\/ckw006 .","journal-title":"Eur J Public Health"},{"key":"598_CR73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/rej.2008.0813","volume":"12","author":"JP Michel","year":"2009","unstructured":"Michel JP, Chidiac C, Grubeck-Loebenstein B, et al. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region. Rejuvenation Res. 2009;12:127\u201335. https:\/\/doi.org\/10.1089\/rej.2008.0813 .","journal-title":"Rejuvenation Res"},{"key":"598_CR74","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1080\/21645515.2016.1150396","volume":"12","author":"S Esposito","year":"2016","unstructured":"Esposito S, Bonanni P, Maggi S, et\u00a0al. Recommended immunization schedules for adults: clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid). Hum Vaccin Immunother. 2016;12:1777\u201394. https:\/\/doi.org\/10.1080\/21645515.2016.1150396 .","journal-title":"Hum Vaccin Immunother"},{"key":"598_CR75","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejim.2013.12.004","volume":"25","author":"S Esposito","year":"2014","unstructured":"ESCMID Vaccine Study Group, Esposito S, Durando P, Bosis S, et al. ESCMID Vaccine Study Group. Vaccine-preventable diseases: from paediatric to adult targets. Eur J Intern Med. 2014;25:203\u201312. https:\/\/doi.org\/10.1016\/j.ejim.2013.12.004 .","journal-title":"Eur J Intern Med"},{"key":"598_CR76","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ypmed.2014.10.017","volume":"69","author":"R Eilers","year":"2014","unstructured":"Eilers R, Krabbe PF, de Melker HE. Factors affecting the uptake of vaccination by the elderly in Western society. Prev Med. 2014;69:224\u201334. https:\/\/doi.org\/10.1016\/j.ypmed.2014.10.017 .","journal-title":"Prev Med"},{"key":"598_CR77","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cger.2016.03.001","volume":"32","author":"G Gnanasekaran","year":"2016","unstructured":"Gnanasekaran G, Biedenbender R, Davidson HE, et\u00a0al. Vaccinations for the older adult. Clin Geriatr Med. 2016;32:609\u201325.","journal-title":"Clin Geriatr Med"},{"key":"598_CR78","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/122.1-2.16","volume":"122","author":"AS Monto","year":"1970","unstructured":"Monto AS, Davenport FM, Napier JA, et\u00a0al. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J\u00a0Infect Dis. 1970;122:16\u201325.","journal-title":"J Infect Dis"},{"key":"598_CR79","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1056\/NEJM200103223441204","volume":"344","author":"TA Reichert","year":"2001","unstructured":"Reichert TA, Sugaya N, Fedson DS, et\u00a0al. The Japanese experience with vaccinating schoolchildren against influenza. N\u00a0Engl J Med. 2001;344:889\u2013886.","journal-title":"N Engl J Med"},{"key":"598_CR80","doi-asserted-by":"publisher","first-page":"3162","DOI":"10.1016\/S0264-410X(03)00253-6","volume":"21","author":"S Esposito","year":"2003","unstructured":"Esposito S, Marchisio P, Cavagna R, et al. Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households. Vaccine. 2003;21:3162\u20138.","journal-title":"Vaccine"},{"key":"598_CR81","doi-asserted-by":"publisher","first-page":"S207","DOI":"10.1097\/01.inf.0000092188.48726.e4","volume":"22","author":"N Principi","year":"2003","unstructured":"Principi N, Esposito S, Marchisio P, et\u00a0al. Socioeconomic impact of influenza on healthy children and their families. Pediatr Infect Dis\u00a0J. 2003;22:S207\u2013S10.","journal-title":"Pediatr Infect Dis J"},{"key":"598_CR82","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.2010.250","volume":"303","author":"M Loeb","year":"2010","unstructured":"Loeb M, Russell ML, Moss L, et\u00a0al. Effect of influenza vaccination of children on infection rates in Hutterite communities: a\u00a0randomized trial. JAMA. 2010;303:943\u201350.","journal-title":"JAMA"},{"key":"598_CR83","doi-asserted-by":"publisher","first-page":"128","DOI":"10.7774\/cevr.2014.3.2.128","volume":"3","author":"K Tae Hyong","year":"2014","unstructured":"Tae Hyong K. Seasonal influenza and vaccine herd effect. Clin Exp Vaccine Res. 2014;3:128\u201332. https:\/\/doi.org\/10.7774\/cevr.2014.3.2.128 .","journal-title":"Clin Exp Vaccine Res"},{"key":"598_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","volume":"15","author":"MR Moore","year":"2015","unstructured":"Moore MR, Link-Gelles R, Schaffner W, et al. Impact of 13-Valent pneumococcal conjugate vaccine used in children on invasive pneumococcal disease in children and adults in the United States: analysis of Multisite, population-based surveillance. Lancet Infect Dis. 2015;15:301\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(14)71081-3 .","journal-title":"Lancet Infect Dis"},{"key":"598_CR85","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Shamez N, et al. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15:535\u201343.","journal-title":"Lancet Infect Dis"},{"key":"598_CR86","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N\u00a0Engl J Med. 2015;372:2087\u201396.","journal-title":"N Engl J Med"},{"key":"598_CR87","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.4161\/21645515.2014.982998","volume":"11","author":"L Tan","year":"2015","unstructured":"Tan L. Adult vaccination: now is the time to realize an unfulfilled potential. Hum Vaccin Immunother. 2015;11:2158\u201366. https:\/\/doi.org\/10.4161\/21645515.2014.982998 .","journal-title":"Hum Vaccin Immunother"},{"key":"598_CR88","volume-title":"Impfungen f\u00fcr Erwachsene im erwerbsf\u00e4higen Alter. Empfehlungen als Erweiterung des \u00d6sterreichischen Impfplans","author":"Bundesministerium f\u00fcr Gesundheit und Frauen","year":"2015","unstructured":"Bundesministerium f\u00fcr Gesundheit und Frauen. Impfungen f\u00fcr Erwachsene im erwerbsf\u00e4higen Alter. Empfehlungen als Erweiterung des \u00d6sterreichischen Impfplans. 2015. http:\/\/www.bmgf.gv.at\/home\/Gesundheit\/Gesundheitsfoerderung_Praevention\/Impfen\/Impfungen_fuer_Erwachsene_im_erwerbsfaehigen_Alter . Zugegriffen: 30.3.2017."},{"key":"598_CR89","volume-title":"Masern-H\u00e4ufung \u2013 was von einer Impfpflicht zu halten ist","author":"Kurier","year":"2017","unstructured":"Kurier. Masern-H\u00e4ufung \u2013 was von einer Impfpflicht zu halten ist. 2017. https:\/\/kurier.at\/wissen\/masern-haeufung-was-von-einer-impfpflicht-zu-halten-ist\/245.193.108 (Erstellt: 7. Febr. 2017). Zugegriffen: 7.2.2017."},{"key":"598_CR90","volume-title":"Impfungen f\u00fcr MitarbeiterInnen des Gesundheitswesens. Empfehlungen als Erweiterung des \u00d6sterreichischen Impfplans","author":"Bundesministerium f\u00fcr Gesundheit und Frauen","year":"2012","unstructured":"Bundesministerium f\u00fcr Gesundheit und Frauen. Impfungen f\u00fcr MitarbeiterInnen des Gesundheitswesens. Empfehlungen als Erweiterung des \u00d6sterreichischen Impfplans. 2012. http:\/\/www.bmgf.gv.at\/home\/Impfempfehlungen_Gesundheitspersonal . Zugegriffen: 30.3.2017."}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-017-0598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-017-0598-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-017-0598-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:52:41Z","timestamp":1659469961000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-017-0598-7"}},"subtitle":["Warum Impfungen auch f\u00fcr Erwachsene wichtig sind","Why vaccinations are also important for adults"],"short-title":[],"issued":{"date-parts":[[2017,9,13]]},"references-count":90,"journal-issue":{"issue":"9-10","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1007\/s10354-017-0598-7","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2017,9,13]]},"assertion":[{"value":"18 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Kunze und E.\u00a0Groman geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}